longevity science
RCTs vs Adaptive Designs Power Next‑Gen Longevity Science?
Adaptive trial designs are poised to outpace traditional randomized controlled trials in propelling next-gen longevity science. Four leading longevity researchers argue that the static nature of conventional randomized controlled trials is the main bottleneck in translating biohacking insights to human healthspan. Medical Disclaimer: This article is for informational purposes only